Brand name :TRANSET Injection
Tranexamic Acid Injection

Tranexamic Acid Injection is a carefully prepared drug solution that suppresses and prevents excessive bleeding across different clinical environments. Tranexamic acid, an antifibrinolytic drug, works by inhibiting the degradation of blood clots and minimising bleeding. Produced with high-quality standards, this injection provides efficient hemostasis and enhanced patient satisfaction in bleeding diseases and surgery.
Tranexamic Acid Injection has tranexamic acid. Tranexamic acid is an
antifibrinolytic agent that acts by retarding the processes that lead to bleeding.
Tranexamic Acid Injection is used for the treatment and prevention of excessive bleeding in haemophilia, von Willebrand disease, or other disorders of hemostasis. It is also employed to decrease blood loss and require transfusion in surgical procedures, especially in orthopaedic, cardiac, and gynaecological operations.
Tranexamic Acid Injection is provided as a sterile solution in vials in concentrations of specified amounts of tranexamic acid suitable for parenteral use. Each vial is precisely made to guarantee proper dosing and maximum therapeutic results.
The product is contraindicated in those with known hypersensitivity to tranexamic acid or any of the excipients. It is not recommended to be administered in cases of active thromboembolic disease, renal disease, or subarachnoid haemorrhage. It is also contraindicated in patients who have a history of venous or arterial thrombosis.
Healthcare professionals need to be careful when prescribing Tranexamic Acid Injection to patients with a history of thromboembolic disorders or renal impairment. Thrombosis, seizures, or hypersensitivity are rare, severe adverse effects. Monitoring of these adverse effects is essential during therapy.
The common adverse effects of Tranexamic Acid Injection are nausea, vomiting, and diarrhea. Occasionally, severe side effects like thromboembolism, seizures, or an allergic reaction can happen. Patients should be instructed to immediately report any unusual symptoms.
The concomitant administration of Tranexamic Acid Injection with other antifibrinolytic drugs or with agents that enhance the risk of thrombosis can enhance the anticoagulant actions of tranexamic acid. Scrutiny of the patient’s drug profile by the healthcare provider is essential to prevent drug interactions.
There is insufficient evidence to establish the safety and efficacy of Tranexamic Acid Injection in pediatric patients, pregnant women, and nursing mothers. The healthcare provider should determine the risks and benefits before prescribing in these populations.
Tranexamic Acid Injection is available as a sterile solution in vials for parenteral administration. Tranexamic Acid Injection should be stored at controlled room temperature. Store away from light and moisture and do not freeze or heat excessively. Any unused portion must be discarded with appropriate procedures for biohazardous waste.
| Packing | 1X5 |
|---|---|
| Composition | Tranexamic Acid 500mg Injection |


(Do Not Post Any Job Queries)